NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for posting your view. I think what you’re trying to say is that a wise company must be prepared, and they must lay the groundwork for manufacturing in advance of regulatory approval. In fact, the capacity to produce the drug is required by regulators. Quite simply, we are living in a new era of cell-based technology. The rapid growth and expansion of the capacity to manufacture cell-based agents is crucial. Any company aiming to commercialize successfully and not be left behind must be prepared to scale up production. CRL recently acquired Cognate Bio and NWBO recently acquired Flaskworks. Those on the cutting edge of this new field of science are preparing to address a global market.

https://p.widencdn.net/ud1zkk/DS-TS-immunology-dendritic-cells-activation-assay







https://www.cnbc.com/video/2021/02/23/charles-river-laboratories-ceo-on-unprecedented-drug-discovery-demand.html

https://virtualtrials.org/dcvax.cfm